Search Results - "Leserer, Saskia"

Time series clustering of T cell subsets dissects heterogeneity in immune reconstitution and clinical outcomes among MUD-HCT patients receiving ATG or PTCy by Leserer, Saskia, Graf, Theresa, Franke, Martina, Bogdanov, Rashit, Arrieta-Bolaños, Esteban, Buttkereit, Ulrike, Leimkühler, Nils, Fleischhauer, Katharina, Reinhardt, Hans Christian, Beelen, Dietrich W, Turki, Amin T

“…Anti-T-lymphocyte globulin (ATG) or post-transplant cyclophosphamide (PTCy) prevent graft-versus-host disease (GVHD) after hematopoietic cell transplantation…”
Get full text

Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG by Turki, Amin T., Tsachakis-Mück, Nikolaos, Leserer, Saskia, Crivello, Pietro, Liebregts, Tobias, Betke, Luisa, Alashkar, Ferras, Leimkühler, Nils B., Trilling, Mirko, Fleischhauer, Katharina, Beelen, Dietrich W.

“…Cytomegalovirus (CMV) reactivation is a frequent complication after allogeneic hematopoietic cell transplantation (HCT), whose impact on clinical outcome, in…”
Get full text

Combined Analysis of Early CD4 + T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation by Leserer, Saskia, Arrieta-Bolaños, Esteban, Buttkereit, Ulrike, Beelen, Dietrich W, Turki, Amin T

“…The incidence and severity of viral complications after cellular therapy are highly variable. Recent publications describe relevant interactions between the…”
Get full text

Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Comparing Post-Transplant Cyclophosphamide Versus Anti-T-Lymphocyte Globulin As Graft-Versus-Host Disease Prophylaxis in a Retrospective Cohort Study by Bogdanov, Rashit, Leserer, Saskia, Bayraktar, Evren, Tsachakis-Mück, Nikolaos, Kasperidus, Lara, Ditschkowski, Markus, Beelen, Dietrich W., Turki, Amin T.

“…Introduction: Both post-transplant cyclophosphamide (PT-Cy) and anti-T-lymphocyte globulin (ATLG) eliminate proliferating allo-reactive T cells after…”
Get full text

Cytomegalovirus kinetics after hematopoietic cell transplantation reveal peak titers with differential impact on mortality, relapse and immune reconstitution by Leserer, Saskia, Bayraktar, Evren, Trilling, Mirko, Bogdanov, Rashit, Arrieta‐Bolaños, Esteban, Tsachakis‐Mück, Nikolaos, Crivello, Pietro, Koldehoff, Michael, Maaßen, Fabienne, Ross, Rudolf Stefan, Fleischhauer, Katharina, Beelen, Dietrich W., Turki, Amin T.

“…Even in the era of PCR‐based monitoring, prophylaxis, and preemptive therapy, Cytomegalovirus (CMV) viremia remains a relevant cause of non‐relapse mortality…”
Get full text

Early Cytomegalovirus Reactivation and Donor Constellation Reduce Early and Late Relapse Incidence of Acute Myeloid Leukemia in a Long-Term Study by Turki, Amin T., Tsachakis-Mück, Nikolaos, Leserer, Saskia, Yi, Ji-Hee, Bayraktar, Evren, Bogdanov, Rashit, Liebregts, Tobias, Steckel, Nina Kristin, Fiedler, Melanie, Beelen, Dietrich W.

“…Introduction After allogeneic cell transplantation (HCT) for acute myeloid leukemia (AML) relapse remains the main cause of morbidity and mortality. Relapse…”
Get full text

Optimizing anti‐T‐lymphocyte globulin dosing to improve long‐term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies by Turki, Amin T., Klisanin, Vesna, Bayraktar, Evren, Kordelas, Lambros, Trenschel, Rudolf, Ottinger, Hellmut, Steckel, Nina K., Tsachakis‐Mück, Nikolaos, Leserer, Saskia, Ditschkowski, Markus, Liebregts, Tobias, Koldehoff, Michael, Fleischhauer, Katharina, Beelen, Dietrich W.

“…Prophylaxis of graft‐versus‐host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HCT) remains challenging. Because prospective…”
Get full text